Literature DB >> 18094955

Mendelian randomisation studies of type 2 diabetes: future prospects.

M S Sandhu1, S L Debenham, I Barroso, R J F Loos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18094955      PMCID： PMC2681076          DOI： 10.1007/s00125-007-0903-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  17 in total

1.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?

Authors:  George Davey Smith; Shah Ebrahim
Journal:  Int J Epidemiol       Date:  2003-02       Impact factor: 7.196

2.  Commentary: development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding'.

Authors:  Martin D Tobin; Cosetta Minelli; Paul R Burton; John R Thompson
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

Review 3.  What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?

Authors:  George Davey Smith; Shah Ebrahim
Journal:  BMJ       Date:  2005-05-07

4.  Nature's randomised trials.

Authors:  Aroon Hingorani; Steve Humphries
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

5.  An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization.

Authors:  Cosetta Minelli; John R Thompson; Martin D Tobin; Keith R Abrams
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

6.  Homocysteine and stroke: evidence on a causal link from mendelian randomisation.

Authors:  Juan P Casas; Leonelo E Bautista; Liam Smeeth; Pankaj Sharma; Aroon D Hingorani
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

Review 7.  Genome-wide association studies provide new insights into type 2 diabetes aetiology.

Authors:  Timothy M Frayling
Journal:  Nat Rev Genet       Date:  2007-09       Impact factor: 53.242

8.  Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.

Authors:  Debbie A Lawlor; Roger M Harbord; Jonathan A C Sterne; Nic Timpson; George Davey Smith
Journal:  Stat Med       Date:  2008-04-15       Impact factor: 2.373

Review 9.  Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials.

Authors:  Dorothea Nitsch; Mariam Molokhia; Liam Smeeth; Bianca L DeStavola; John C Whittaker; David A Leon
Journal:  Am J Epidemiol       Date:  2006-01-12       Impact factor: 4.897

10.  Insight into the nature of the CRP-coronary event association using Mendelian randomization.

Authors:  Juan P Casas; Tina Shah; Jackie Cooper; Emma Hawe; Alex D McMahon; Dairena Gaffney; Christopher J Packard; Denis S O'Reilly; Irene Juhan-Vague; John S Yudkin; Elena Tremoli; Maurizio Margaglione; Giovanni Di Minno; Anders Hamsten; Teake Kooistra; Jeffrey W Stephens; Steven J Hurel; Shona Livingstone; Helen M Colhoun; George J Miller; Leonelo E Bautista; Tom Meade; Naveed Sattar; Steve E Humphries; Aroon D Hingorani
Journal:  Int J Epidemiol       Date:  2006-03-24       Impact factor: 7.196
View more
  5 in total

1.  RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans.

Authors:  Ying Wu; Huaixing Li; Ruth J F Loos; Qibin Qi; Frank B Hu; Yong Liu; Xu Lin
Journal:  J Lipid Res       Date:  2009-03-14       Impact factor: 5.922

2.  A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study).

Authors:  Ali S Murad; George Davey Smith; Sarah J Lewis; Angela Cox; Jenny L Donovan; David E Neal; Freddie C Hamdy; Richard M Martin
Journal:  Int J Mol Epidemiol Genet       Date:  2010-04-01

3.  Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009.

Authors:  James B Meigs
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

4.  Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans.

Authors:  Chen Liu; Huaixing Li; Lu Qi; Ruth J F Loos; Qibin Qi; Ling Lu; Wei Gan; Xu Lin
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

5.  Mendelian randomization studies of biomarkers and type 2 diabetes.

Authors:  Ali Abbasi
Journal:  Endocr Connect       Date:  2015-10-07       Impact factor: 3.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.